A Triad of Costimulatory Molecules Synergize to Amplify T‐‐Cell Activation in Both Vector‐‐Based and Vector‐‐Infected Dendritic Cell Vaccines

References

• Albert M. L., Pearce S. F., Francisco L. M., Sauter B., Roy P., Silverstein R. L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross‐‐present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998; 188: 1359–1368
   PubMed Web of Science ®Google Scholar
• Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl‐‐XL. Immunity 1995; 3: 87–98
   PubMed Web of Science ®Google Scholar
• Boussiotis V. A., Lee B. J., Freeman G. J., Gribben J. G., Nadler L. M. Induction of T cell clonal anergy results in resistance, whereas CD28‐‐mediated costimulation primes for susceptibility to Fas‐‐ and Bax‐‐mediated programmed cell death. J. Immunol. 1997; 159: 3156–3167
   PubMedGoogle Scholar
• Cavallo F., Martin‐‐Fontecha A., Bellone M., Heltai S., Gatti E., Tornaghi P., Freschi M., Forni G., Dellabona P., Casorati G. Co‐‐expression of B7‐‐1 and ICAM‐‐1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 1995; 25: 1154–1162
   PubMed Web of Science ®Google Scholar
• Damle N. K., Klussman K., Linsley P. S., Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM‐‐1, LFA‐‐3, and VCAM‐‐1 on resting and antigen‐‐primed CD4++ T lymphocytes. J. Immunol. 1992; 148: 1985–1992
   PubMed Web of Science ®Google Scholar
• Delespesse G., Yang L. P., Ohshima Y., Demeure C., Shu U., Byun D. G., Sarfati M. Maturation of human neonatal CD4++ and CD8++ T lymphocytes into Th1//Th2 effectors. Vaccine 1998; 16: 1415–1419
   PubMed Web of Science ®Google Scholar
• Dubey C., Croft M., Swain S. L. Costimulatory requirements of naïve CD4++ T cells. ICAM‐‐1 or B7‐‐1 can costimulate naïve CD4 T‐‐cell activation, but both are required for optimum response. J. Immunol. 1995; 155: 45–57
   PubMed Web of Science ®Google Scholar
• Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Steinman R., Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999; 163: 6762–6768
   PubMed Web of Science ®Google Scholar
• Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J., Nadler L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor. Blood 1994; 84: 3261–3282
   PubMed Web of Science ®Google Scholar
• Hellstrom K. E., Hellstrom I., Linsley P., Chen L. On the role of costimulation in tumor immunity. Ann. N. Y. Acad. Sci. 1993; 690: 225–230
   PubMed Web of Science ®Google Scholar
• Hellstrom K. E., Chen L., Hellstrom I. Costimulation of T cell‐‐mediated tumor immunity. Cancer Chemother. Pharmacol. 1996; 38: S40
   Google Scholar
• Hodge J. W., McLaughlin J. P., Abrams S. I., Shupert W. L., Schlom J., Kantor J. A. The admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor associated antigen gene results in enhanced specific T‐‐cell responses and anti‐‐tumor immunity. Cancer Res. 1995; 55: 3598–3603
   PubMed Web of Science ®Google Scholar
• Hodge J. W., McLaughlin J. P., Kantor J. A., Schlom J. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non‐‐replicating avian pox virus to enhance T‐‐cell immunity and antitumor responses. Vaccine 1997; 15: 759–768
   PubMed Web of Science ®Google Scholar
• Hodge J. W., Sabzevari H., Yafal A. G., Gritz L., Lorenz M. G.O., Schlom J. A triad of costimulatory molecules synergize to amplify T‐‐cell activation. Cancer Res. 1999; 59: 5800–5807
   PubMed Web of Science ®Google Scholar
• Hodge J. W., Rad A. N., Grosenbach D. W., Sabzevari H., Yafal A. G., Gritz L., Schlom J. Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules. J. Natl. Cancer Inst. 2000; 92: 1228–1239
   PubMed Web of Science ®Google Scholar
• Kalus R. M., Kantor J. A., Gritz L., Yafal A. G., Mazzara G. P., Schlom J., Hodge J. W. The use of combination vaccinia vaccines to enhance antigen‐‐specific T‐‐cell immunity via T‐‐cell costimulation. Vaccine 1999; 17: 893–903
   PubMed Web of Science ®Google Scholar
• Kass E., Schlom J., Thompson J., Guadagni F., Greiner J. W. Induction of protective host immunity to carcinoembryonic antigen ((CEA)), a self‐‐antigen in CEA‐‐transgenic mice, by immunizing with a recombinant vaccinia‐‐CEA virus. Cancer Res. 1999; 59: 676–683
   PubMed Web of Science ®Google Scholar
• Labeur M. S., Roters B., Pers B., Mehling A., Luger T. A., Schwarz T., Grabbe S. Generation of tumor immunity by bone marrow‐‐derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 1999; 162: 168–175
   PubMed Web of Science ®Google Scholar
• Morse M. A., Lyerly H. K., Gilboa E., Thomas E., Nair S. K. Optimization of the sequence of antigen loading and CD40‐‐ligand‐‐induced maturation of dendritic cells. Cancer Res. 1998; 58: 2965–2968
   PubMed Web of Science ®Google Scholar
• Ockenhouse C. F., Sun P. F., Lanar D. E., Wellde B. T., Hall B. T., Kester K., Stoute J. A., Magill A., Krzych U., Farley L. Phase I//IIa safety, immunogenicity, and efficacy trial of NYVAC‐‐Pf7, a pox‐‐vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J. Infect. Dis. 1998; 177: 1664–1673
   PubMed Web of Science ®Google Scholar
• Parra E., Wingren A. G., Hedlund G., Sjogren H. O., Kalland T., Sansom D., Dohlsten M. Human naïve and memory T‐‐helper cells display distinct adhesion properties to ICAM‐‐1, LFA‐‐3 and B7 molecules. Scand. J. Immunol. 1993; 38: 508–514
   PubMedGoogle Scholar
• Parra E., Wingren A. G., Hedlund G., Kalland T., Dohlsten M. The role of B7‐‐1 and LFA‐‐3 in costimulation of CD8++ T cells. J. Immunol. 1997; 158: 637–642
   PubMedGoogle Scholar
• Porgador A., Snyder D., Gilboa E. Induction of antitumor immunity using bone marrow‐‐generated dendritic cells. J. Immunol. 1996; 156: 2918–2926
   PubMed Web of Science ®Google Scholar
• Reed J. C. Bcl‐‐2 and the regulation of programmed cell death. J. Cell Biol. 1994; 124: 1–6
   PubMed Web of Science ®Google Scholar
• Rescigno M., Winzler C., Delia D., Mutini C., Lutz M., Ricciardi‐‐Castagnoli P. Dendritic cell maturation is required for initiation of the immune response. J. Leukoc. Biol. 1997; 61: 415–421
   PubMed Web of Science ®Google Scholar
• Specht J. M., Wang G., Do M. T., Lam J. S., Royal R. E., Reeves M. E., Rosenberg S. A., Hwu P. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 1997; 186: 1213–1221
   PubMed Web of Science ®Google Scholar
• Sperling A. I., Auger J. A., Ehst B. D., Rulifson I. C., Thompson C. B., Bluestone J. A. CD28//B7 interactions deliver a unique signal to naïve T cells that regulates cells survival but not early proliferation. J. Immunol. 1996; 157: 3909–3917
   PubMed Web of Science ®Google Scholar
• Thompson J. A., Grunert F., Zimmerman W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal. 1991; 5: 344–366
   PubMed Web of Science ®Google Scholar
• Wingren A. G., Parra E., Varga M., Kalland T., Sjogren H. O., Hedlund G., Dohlsten M. T‐‐cell activation pathways: B7, LFA‐‐3, and ICAM‐‐1 shape unique T‐‐cell profiles. Crit. Rev. Immunol. 1995; 15: 235–253
   PubMed Web of Science ®Google Scholar
• Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V. S., Davoust J., Ricciardi‐‐Castagnoli P. Maturation stages of mouse dendritic cells in growth factor‐‐dependent long‐‐term cultures. J. Exp. Med. 1997; 185: 317–328
   PubMed Web of Science ®Google Scholar